Literature DB >> 7760098

Growth inhibition of subcutaneously transplanted human glioma by transfection-induced tumor necrosis factor-alpha and augmentation of the effect by gamma-interferon.

K Harada1, J Yoshida, M Mizuno, K Sugita, K Kurisu, T Uozumi.   

Abstract

Using subcutaneous solid tumors produced by U251-MG human glioma cells, we studied the in vivo transfection of the cells with the tumor necrosis factor-alpha (TNF-alpha) gene delivered by means of liposomes. When the tumor had become 7 mm in diameter, liposomes with entrapped TNF-alpha gene were injected into the center of the subcutaneous tumor. We found that mRNA of transfection-induced TNF-alpha, which was expressed in the tumor tissue, was detected by reverse transcriptase-polymerase chain reaction (RT-PCR) method and its protein was demonstrated by enzyme-linked immunoassay. Growth of the tumor was inhibited when the injection was carried out five times at every other day. The growth-inhibitory effect by transfection-induced TNF-alpha was much remarkable as compared with exogenous TNF-alpha and the effect was enhanced by the intraperitoneal injection of gamma-interferon (IFN-gamma) 12 h prior to intratumoral injection of the liposomes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7760098     DOI: 10.1007/BF01052922

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  13 in total

1.  Proposal of standardized methods and reference for assaying recombinant human tumor necrosis factor.

Authors:  S Yamazaki; E Onishi; K Enami; K Natori; M Kohase; H Sakamoto; M Tanouchi; H Hayashi
Journal:  Jpn J Med Sci Biol       Date:  1986-06

2.  mRNA phenotyping by enzymatic amplification of randomly primed cDNA.

Authors:  K E Noonan; I B Roninson
Journal:  Nucleic Acids Res       Date:  1988-11-11       Impact factor: 16.971

3.  Antitumor effect of recombinant human lymphotoxin on a tumor line of human malignant glioma.

Authors:  T Mikami; K Kurisu; K Kiya; K Mukada; K Kawamoto; T Hotta; T Uozumi
Journal:  Hiroshima J Med Sci       Date:  1989-09

4.  Growth inhibition of glioma cells transfected with the human beta-interferon gene by liposomes coupled with a monoclonal antibody.

Authors:  M Mizuno; J Yoshida; K Sugita; I Inoue; H Seo; Y Hayashi; T Koshizaka; K Yagi
Journal:  Cancer Res       Date:  1990-12-15       Impact factor: 12.701

5.  Clinical effect of intra-arterial tumor necrosis factor-alpha for malignant glioma.

Authors:  J Yoshida; T Wakabayashi; M Mizuno; K Sugita; T Yoshida; S Hori; T Mori; T Sato; A Karashima; K Kurisu
Journal:  J Neurosurg       Date:  1992-07       Impact factor: 5.115

6.  Differential effects of tumor necrosis factor on the growth and differentiation of neuroblastoma and glioma cells.

Authors:  M A Muñoz-Fernández; R Armas-Portela; J Díaz-Nido; J L Alonso; M Fresno; J Avila
Journal:  Exp Cell Res       Date:  1991-05       Impact factor: 3.905

7.  Effects of recombinant human tumor necrosis factor on rodent gliomas and normal brain.

Authors:  J C Kiwit; K H Schmitz; L Daum; G Reifenberger; N Roosen
Journal:  J Neurosurg       Date:  1991-10       Impact factor: 5.115

8.  Monocyte tumoricidal activity and tumor necrosis factor production in patients with malignant brain tumors.

Authors:  B P Barna; L R Rogers; M J Thomassen; G H Barnett; M L Estes
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

9.  Antitumor synergism between recombinant human tumor necrosis factor and recombinant human interferon-r.

Authors:  N Watanabe; Y Niitsu; N Yamauchi; H Umeno; H Sone; H Neda; I Urushizaki
Journal:  J Biol Response Mod       Date:  1988-02

10.  Transfection-induced tumor necrosis factor-alpha increases the susceptibility of human glioma cells to lysis by lymphokine-activated killer cells: continuous expression of intercellular adhesion molecule-1 on the glioma cells.

Authors:  T Takaoka; J Yoshida; M Mizuno; K Sugita
Journal:  Jpn J Cancer Res       Date:  1994-07
View more
  6 in total

1.  Interleukin-6 transduction of a rat T9 glioma clone results in attenuated tumorigenicity and induces glioma immunity in Fischer F344 rats.

Authors:  M R Graf; R E Merchant
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

2.  Transformation of rat glioma cells with the M-CSF gene inhibits tumorigenesis in vivo.

Authors:  H Yoshioka; S Hama; T Sadatomo; E Taniguchi; K Harada; K Sugiyama; F Kimura; K Motoyoshi; K Kurisu
Journal:  J Neurooncol       Date:  1998-12       Impact factor: 4.130

3.  A Rare but Morbid Occurrence: Development of Glioblastoma Multiforme During Tumor Necrosis Factor Inhibitor Therapy.

Authors:  Laura S Kraemer; Ross J Humes; Azfar S Syed; Adam M Tritsch
Journal:  Cureus       Date:  2022-05-15

Review 4.  Current review of in vivo GBM rodent models: emphasis on the CNS-1 tumour model.

Authors:  Valerie L Jacobs; Pablo A Valdes; William F Hickey; Joyce A De Leo
Journal:  ASN Neuro       Date:  2011-08-03       Impact factor: 4.146

5.  Current and Future Gene Therapy for Malignant Gliomas.

Authors:  Takao Kanzawa; Hideaki Ito; Yasuko Kondo; Seiji Kondo
Journal:  J Biomed Biotechnol       Date:  2003

6.  Adenovirus-mediated gene transduction of IkappaB or IkappaB plus Bax gene drastically enhances tumor necrosis factor (TNF)-induced apoptosis in human gliomas.

Authors:  N Shinoura; N Yamamoto; Y Yoshida; T Fujita; N Saito; A Asai; T Kirino; H Hamada
Journal:  Jpn J Cancer Res       Date:  2000-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.